Coherus Biosciences Inc (NASDAQ: CHRS), a Redwood City, California, company, gained to close at $16.73 Friday after gaining $0.05 (0.30%) on volume of 454,575 shares. The stock ranged from a high of $16.96 to a low of $16.38 while Coherus’s market cap now stands at $1,279,512,943.
About Coherus Biosciences Inc
Coherus is a commercial stage biopharmaceutical company with the mission to increase access to cost-effective medicines that can have a major impact on patients’ lives and to deliver significant savings to the health care system.